p53 protein accumulation, thought to be caused by p53 gene mutation, is closely related to poor prognosis of patients with certain types of carcinomas. The progression of esophageal squamous cell carcinoma (SCO is also strongly suspected to depend on the p53 tumor suppressor gene. Formalin-fixed, paraffin-embedded sections were taken from 25 patients who underwent esophagectomy for SCC. Fourteen patients had no preoperative therapy (control group), while the other 11 patients received preoperative radiotherapy (radiation group). There was no difference in pathological T N M classification between the two groups. These sections were examined by immunostaining with monoclonal antibody PAb 1801 to determine the accumulation of p53 protein , and apoptotic frequency was determined by TdT mediated dUTP-biotin nick end-labeling (TUNEL). In the control group, well to moderately differentiated cases showed a significantly higher Al (apoptotic index which is the number of apoptotic cells among 1000 cancer cells. 96o) (51.7±83.4) than poorly differentiated cases (AI = 1.3±1.0) (P<0.05). Similar results were obtained in the radiation group. The former group included 4 cases of p53 grade 4 (p53 protein detected in over 70% of the tumor cells), and the latter included 2. Few apoptotic cells were observed in any of 6 tumor tissues. In each patient, tumor cells with accumulated p53 protein were very rare to be apoptotic. On the other hand, apoptosis was observed in tumor cells without p53 protein accumulation. Spontaneous apoptosis in esophageal SCC can be induced more easily in differentiated than in poorly differentiated cases. This tendency may be enhanced by preoperative radiotherapy. Extensive p53 protein may suppress apoptotic induction in esophageal squamous cell carcinomas. (Jpn J Clin Oncol 26: 398-404, 1996) 
Introduction five-year survival of patients with esophageal squamous cell carcinoma (SCC) in Japan has improved following the introduction of radical lymph node dissection with adjuvant therapies. However, it is still only 23.7%," and especially at the invasive stage (pT2-4), the prognosis is worse than for other carcinomas of the gastrointestinal tract, necessitating a new strategy to overcome this problem.
Recently, it has become accepted that cell death through apoptosis is induced in some tumors by anticancer agents, 2 ' 3) and this is considered to be a Received: January 26, 1996 Accepted: May 20, 1996 For reprints and all correspondence: Madoka Hamada, Department of Surgery I, Okayama University Medical School, 5-1, Shikata-cho 2-chome, Okayama 700 possible new strategy for suppressing cancer progression. The p53 tumor suppressor gene that upregulates the box gene and p21 is one of the most important genes for cancer growth suppression. The former gene has a wild-type p53 binding site but not a mutated one in the promoter region, and is considered a primary-response gene for apoptotic induction. 41 The latter protein is considered to induce Gl arrest of various cells, 56 ' and to suppress the replication of damaged DNA by binding to proliferating-cell nuclear antigen in S phase. 7 ' p21 and bax can also be induced through other pathways, 8 ' but the p53 pathway is the best known and is considered the most likely target for a new strategy."
In human breast cancer 10 ' and lung SCC, 1 " p53 protein accumulation has been immunohistochemically detected, and is correlated with mutation of the p53 gene. In breast cancer, p53 protein ac-cumulation has been proved to be a prognostic marker. In Huixian county, Henan Province, China, p53 protein accumulation and gene mutation is considered to occur at an early stage of esophageal SCC, 12 ' 13) and this has already been demonstrated in head and neck SCC.
14 As p53 protein overexpression in esophageal carcinoma is also indicative of a poor prognosis, it is suspected that loss of normal function of p53 may suppress the susceptibility to apoptosis or impair cell cycle control. 15 ' In the p53-null mouse, the loss of p53 essentially renders epithelial cells from both the small intestine and colon radioresistant. 16 ' In adenovirus ElA-expressing mouse embryonal fibroblasts, p53 is required for efficient activation of apoptosis. 17 ' Sarcomas with wild-type p53 induced in nude mice form fewer tumors with longer latency, and are more sensitive to irradiation than /?53-deficient ones. 18 ' These results suggest that some human tumors may require the wild-type p53 tumor suppressor gene for sufficient radiosensitivity.
The purpose of this study was to determine the correlation between spontaneous apoptosis and p53 accumulation, and to evaluate the effect of radiation on apoptosis in esophageal SCC, especially that with p53 protein overexpression.
Materials and Methods

Patients and Samples
Formalin-fixed, paraffin-embedded tumor specimens were obtained from 25 patients with esophageal cancer, aged 42-84 years (mean±SD 61.5 ±10.1, 23 men, 2 women), whose tumors were surgically resected in our department between 1985 and 1994. All the tumors were SCC and the patients were divided into 2 groups, a control group (cases 1-14) and a radiation group (cases 15-25); each group was further divided into 2 subgroups according to the degree of tumor differentiation. (Table I ) The control group included 14 patients aged 47-84 years (64.1 ±9.9, 13 men and 1 woman) who received no preoperative therapy. The radiation group included 11 patients aged 42-77 years (58.3 ±9.7, 10 men and 1 woman) who were irradiated with 30 Gy or 40 Gy 7-14 days before surgery without any other preoperative adjuvant therapy. There was no significant difference in pathologic TNM classification between the two groups. All experiments were performed at least twice on each section, and 1-8 blocks were used for each tumor.
Histological Differentiation
All specimens were reviewed by two experienced pathologists to identify the differentiation of each SCC. Sections (3 /an thick) were mounted on Silanized Slides (DAKO Japan Co., Ltd., Tokyo).
Determination of Apoptotic Cells
Serial sections were stained with hematoxylin and eosin (H/E) and with terminal deoxynucleotidyl transferase (TdT)-mediated dUTP-biotin nick endlabeling (TUNEL) 19 ' to identify the apoptotic cells.
TUNEL
Formalin-fixed, paraffin-embedded sections were deparaffinized, washed with distilled water (DW), and incubated with proteinase K (20 /tg/ml) (Boehringer Mannheim Biochemica, Mannheim) in 10 mM Tris-HCl buffer (pH 7.4) for 20 min at room temperature (RT). The sections were washed in DW 4 times for 2 min each time and incubated with 2% aqueous H 2 O 2 for 10 min at RT to inactivate endogenous peroxidase. The sections were then washed in DW 4 times for 1 min each time, and immersed in TdT buffer solution (0.1 M potassium cacodylate, 2 mM CoCl 2 , 0.2 mM DTT, pH7.2) (GIBCO BRL Life Technologies, Inc., Gaithersburg) 4 times for 2 min each time at RT. TdT (0.3 e.u./ml) (GIBCO BRL Life Technologies, Inc.) and biotinylated dUTP (0.08 nm/ml) (Boehringer Mannheim Biochemica) in TdT buffer solution were then added to the sections. The sections were covered with coverslips and incubated in a moist chamber at 37°C for 6CL min. After removal of the coverslips, the sections were then washed in TB buffer (300 mM sodium chloride, 30 mM sodium citrate) for 15 min at RT. The sections were then washed with DW, rinsed with phosphate-buffered saline (PBS) for 1 min and covered with 10% normal rabbit serum for 10 min. This was followed by a wash with DW, then with PBS for 5 min, followed by incubation with streptavidin-labeled peroxidase for 30 min at 37°C. They were then washed with DW for 3 min and with PBS 3 times for 5 min each time, followed by incubation in diaminobenzidine/H2O 2 solution (DAB substrate kit, Histfine, Tokyo) for 10-15 min at room temperature. For counterstaining, the sections were incubated in 1% aqueous methyl green solution for 10 h. As a positive control, tissue sections were treated with DNase 1 (0.7 /tg/ml potassium cacodylate buffer, pH 7.2) for 10 min before treatment with TdT. As a negative control, the sections were treated according to the same procedure but without TdT.
By comparing the TUNEL results with H/E staining on serial sections, we were able to determine which TUNEL-positive cells were apoptotic or necrotic. Neglecting the necrotic cells, the remaining nick end-positive cells were apoptotic. The frequency of apoptotic cells was counted in 5 Table   Sex pT   3  3  3  3  3  3  3  3  3  2  2  3  3  4   3  3  2  3  3  3  3  3  2 III  IIA  III  IIA  III  III  IIA  III  III  IIA  IIB  III  III  III   III  HI  IIA  IV  III  IIA  III  III  IIB  III  IIB   G   1  1  1  1  1  2  2  2  2  2  3  3  3  3   1  1  1  1  2  2  2  2  2 randomly chosen tumor nests at a magnification of X400 to calculate the apoptotic index (AI = average ±SD), which is the number of apoptotic cells among 1000 cancer cells (p/oo).
Immunohistochemical Staining to Identify p53 Protein Accumulation
The formalin-fixed, paraffin-embedded sections were deparaffinized, washed with DW for 5 min incubated with 0.3% H 2 O 2 in methanol for 30 min to inactivate endogenous peroxidase. After washing with PBS, these sections were boiled in citrate buffer solution (pH 6.0) in an autoclave at 120°C for 15 min. 20 ' After washing in PBS for 20 min, the sections were incubated in normal horse serum for 20 min at room temperature, then with primary antibody for 12 h at 4°C in a moist chamber. Using a Vectastain Elite Kit (Vector Laboratories, Burlingame, CA), the biotinylated secondary antibody was applied (incubated for 30 min at RT), then avidin-biotin complex conjugated to horseradish peroxidase was applied (incubated for 30 min at room temperature). After washing in PBS for 10 min, these sections were incubated in DAB/H2O2 solution (DAB substrate Kit, Histfine, Tokyo) for 10-15 min at RT. As a negative control, the primary antibody was exchanged for mouse IgG in this procedure. For counterstaining, these sections were incubated in methyl green solution. As a primary antibody, we used mouse monoclonal antibody PAb 1801 (diluted 1:500), which recognizes a denaturation-resistant epitope of human p53 protein located between amino acids 32 and 79.
Microscopic examination for the p53 nuclear reaction was graded as follows: grade 1, 0-10% of cancer cells stained; grade 2, 10-40% of cancer cells stained; grade 3, 40-70% of cancer cells stained; grade 4, over 70% of cancer cells stained.
Statistical Analysis
Statistical analysis was performed by unpaired t test, x-squared test and Fisher's exact test. Differences at P<0.05 were considered significant.
Results
Apoptotic Frequency and Differentiation
In the untreated control group, well to moderately differentiated cases contained many apoptotic (Fig. 1, A-C) . On the other hand, poorly differentiated cases contained few apoptotic cells (AI = 1.3±1.0) (Fig. 1, D) . The former group contained significantly more apoptotic cells than the latter. (Table II) 
Preoperative Radiotherapy and Apoptosis
The radiotherapy group contained more apoptotic cells (AI= 117.8 ±158.3) than the control group (AI = 37.3±73.3), but not to a significant extent. This group included 9 cases of well to moderately differentiated SCC (81.8% of this group), and two poorly differentiated (18.2%) cases. AI of the former (AI = 143.7±164.9) was very high, but the latter (AI = 1.5±0.7) contained few apoptotic cells (P<0.05). 
Differentiation and p53 Staining Pattern
In the control group, there was no relationship between p53 grade and differentiation. On the other hand, in the radiation group, 8 well/moderately differentiated cases were grade 1, but all poorly differentiated cases were grade 4. (Table III) 
Apoptotic Frequency and p53 Staining Pattern
In the control group, the cases of higher grade p53 showed a lower AI. (Table IV) AI of cases with p53 grade 4 was 3.5 ±5.7, but that of cases with p53 grade 1 was 60.8 ±91.9 (not significant). In the radiotherapy group, cases with p53 grade 4 also contained few apoptotic cells (AI = 1.5±0.7). On the other hand, cases with grade 1 contained far more apoptotic cells (AI = 153.8±173.2). In each case, p53-positive cells were rarely apoptotic (Fig. 2, A, B) , and almost all apoptotic cells observed had no p53 overexpression (Fig. 2, C, D) . Discussion p53 protein accumulation in SCC is now considered to be caused by a mutation of the p53 tumor suppressor gene, which makes a more stable protein than the wild-type p53 gene, and it is not thought to be due to an increase in the steady-state level of p53 mRNA of carcinoma cells. 20 It is true that wild-type p53 protein is also detectable by immunohistochemical staining in tumors harboring wild-type p53, but in such cases, p53-positive cells are rarely observed in the tumor.
22
* We have stained cancer cell clones harboring wild-type p53 and it was proved that cancer cells expressing p53 protein were rarely present.
p53 protein accumulation, which is detected by immunohistochemical staining, is related to poor prognosis in some types of tumors, and one of these is 23 ' 24 ' esophageal carcinoma. 15) Although the mechanism of the relationship is not clearly understood, apoptosis and cell cycle arrest through the p55-dependent pathway may play an important role in suppressing the progression of the cancer.
A higher grade of p53 protein accumulation means a lower frequency of apoptotic cells in the tumor. Our data indicated no clear relationship between p53 protein accumulation and differentiation, but around the cancer pearls, which contained many apoptotic cells, p53 protein had not accumulated. On the other hand, tumor cells with accumulated p53 contained few cancer pearls. These results suggest that the wild-type p53 tumor suppressor gene is necessary for both progression of differentiation and susceptibility to apoptosis.
In Wilms' tumor, which contains generally no p53 gene mutations, the anaplastic histological variant is frequently associated with p53 gene mutations and a poor prognosis, in spite of current protocols for adjuvant therapy. Furthermore, this variant shows attenuated apoptosis. 251 This characteristic of anaplastic-type Wilms' tumor is similar to poorly differentiated SCC.
The effect of radiotherapy is now considered to be an apoptotic reaction; it has already been demonstrated that irradiation can induce apoptosis in some murine tumors. 26 ' Our data show (Table  II) that an apoptotic reaction in some esophageal squamous cell carcinomas was induced by ionizing radiation. Interestingly, the differentiation of the tumors was related to the frequency of spontaneous apoptosis. In the radiation group, most of the cases were well to moderately differentiated (9/11), and only two were poorly differentiated. In head and neck SCC, ionizing radiation induces intracellular filaments and desmosomes that are part of the keratinization pattern in tumors which show a good response to irradiation. 27 ' Therefore, ionizing radiation may not only induce apoptosis but may also contribute to the differentiation of SCC.
It is suspected from these results that differentiation is also necessary for the induction of apoptosis by ionizing radiation, and it may be related to the p53 tumor suppressor gene. p53 gene mutations contribute to tumor resistance against radiotherapy, as reported by Lowe et al., and possibly the resistant tumor cells would not be differentiated. Most cases with overexpression of p53 protein showed heterogeneity of p53 immunostaining. Even in the poorly differentiated cases, some clones harboring the wild-type p53 gene would be differentiated after induction of DNA damage by ionizing radiation. We consider that the wild-type p53 tumorsuppressor gene induces apoptosis, and, at the same time, may play an important role in the differentiation pathway, for example through p21 upregulation. 8 -29) As the 5-year survival rate of patients with esophageal SCC is still very poor, in spite of the development of aggressive operations with some adjuvant therapies, a new strategy is necessary for this carcinoma, especially in the invasive stage. Locally advanced non-small cell lung cancer with aberrant p53 expression is reported to be resistant to cisplatin-based chemotherapy, 30 ' and p53 gene introduction into lung carcinoma harboring the mutated p53 gene is expected to make it sensitive to cisplatin. 9 ' Our data suggest that introduction of the wild-type p53 gene into a tumor extensively expressing p53 protein would induce apoptosis in the tumor. Furthermore, the radiosensitivity of the tumor may be improved by this gene introduction. The /?53-independent pathway for apoptosis may also control esophageal squamous cell carcinoma progression, 8 ' but the /?55-dependent pathway is one of the most important mechanisms for this tumor suppression.
